Overview:
Expression vectors are the cloning vectors that possess suitable expression signals to provide highest gene expression. Expression vectors usually aids to present a gene of interest in a targeted cell which further catalyzes the mechanism of cell to create a protein encoded by gene. Expression vectors are applied for manufacturing of therapeutic agents, constantly activated proteins for biophysical, biochemical, & structural studies, and huge capacities of proteins for industrial applications. Expression vectors are also used for manufacturing of enzymes, insulin, antibiotics, vaccines, growth hormones, and antibodies. Expression vectors market experiences steady growth mainly driven by the rising demand for protein-based drugs, increasing prevalence of lifestyle, genetic, & infectious disorders, and mounting R&D activities due to pouring investments in protein therapy. The key factors restraining the market growth are increasing market consolidation, stringent regulatory policies assisting the market entry barriers, and huge cost of protein therapy.
Bacterial expression vectors is observed as the largest market segment due to high rate of transformation and organized transformation protocols. During the forecast period 2018 – 2026, mammalian expression vectors segment was observed as the fastest growing market due to mammalian host system’s capability to perform process of recombinant proteins, folding, and multifaceted post-translational alterations. Pharmaceutical industry was observed as the largest end-user market due to rising demand for biological treatments especially against chronic disease, and rising research and development activities for novel drug therapies.
North America was observed as the largest expression vectors market due to key market drivers such as incessant progress in research & development of novel therapeutics, rising demand for efficient and safe drug therapies, and rising prevalence of chronic diseases coupled with public awareness. During the forecast period 2018 – 2026, Asia Pacific will grow at a fastest CAGR due rapid growth in pharmaceutical & biotechnology industries, rising research and development infrastructure in healthcare industry, and increasing demand for effective drugs in chronic diseases treatment.
The expression vectors market is segmented on the following bases:
- Host
- Bacterial Expression Vectors
- E.Coli Expression Vectors
- Other Bacterial Expression Vectors
- Insect Expression Vectors
- Baculovirus Expression Vectors
- Other Insect Expression Vectors
- Mammalian Expression Vectors
- CHO Expression Vectors
- Other Mammalian Expression Vectors
- Yeast Expression Vectors
- K. Lactis Expression Vectors
- Pichia Pastoris Expression Vectors
- Saccharomyces Cerevisiae Expression Vectors
- Other Yeast Expression Vectors
- End User
- Pharmaceutical & Biotechnology Industry
- Contract Research Organizations & Contract Manufacturing Organization
- Academic Research Institutes
- Geography
- North America
- Europe
- United Kingdom
- Germany
- Rest of Europe
- Asia Pacific
- Japan
- China
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
Key players identified for expression vectors market includes:
Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Agilent Technologies, Promega Corporation, Bio-Rad Laboratories, New England Biolabs, Life Technologies Corporation, Clontech Laboratories, Inc., Merck Millipore, QIAGEN, and GenScript USA Inc.
This report offers:
- Market assessment is done by furnishing the market size and compounded annual growth rate considering 2017 as the base year and period from 2018 to 2026 as the forecast period
- For the geography, host, and end user segments, attractive investment proposition is given which helps expression vector manufacturers to contemplate useful financial decisions
- Competitive landscape helps in determining the competitive milieu currently existing in the expression vectors market
- Financial health of leading players is considered in the financial information segment and diverse range of expression vectors are covered in the product portfolio section. Recent news coverage keeps us informed regarding the latest strategic developments and their impact on the expression vectors market.
